A Conversation with Travera

Down There Aware

This week Mary and Alex speak with Cliff Reed, Founding CEO, and Dennis Watson, VP Business Development, of Travera, a company specializing in new technology enhancing the landscape of late stage cancer treatment.

Listen on our website, www.downthereaware.com/podcast, or wherever you get your podcasts.

#Podcast #Spotify #Anchor #research #advocacy #cancer #Travera #genomics #DNA #MIT #FDA #CLIA #LDT #cancerresearch #technology #cancertechnology #innovation #groundbreaking #latestagecancer #stage4cancer #uterinecancer #ovariancancer #leukemia

Stay Connected

Email Us: [e-mail]

Instagram:@downthereaware

Facebook: Down There Aware

Twitter: @downthereaware

Pinterest: Down There Aware

TikTok: Down There Aware

Episode Links

TRAVERA

Episode Highlights

• Intro [0:13]

• Welcome Back! [1:25]

• Guest introductions [1:44]

• M.I.T. technology [3:42]

• Genomics and DNA sequencing [3:58]

• Limited patients [4:05]

• New measurement tool [4:48]

• MIT/Dana Farber Cancer Institute partnership [5:32]

• Infectious disease comparison [5:48]

• Multiple Myeloma [6:38]

• “Cheat code” [7:30]

• Commercial launch [9:09]

• Test offered for free [10:15]

• Working with physicians [10:55]

• Trial and error process for patient [13:20]

• Advocacy groups [15:25]

• Patient profile [16:01]

• Cancer mutation [17:57]

• Access to live cancer cells [18:38]

• Quick turn-around for results[21:30]

• No additional burden on patient [23:35]

• Early stage testing and limited data [24:28]

• Predictive accuracy over 80% [25:12]

• Late stage cancer patients [26:25]

• Response from oncology community [28:00]

• Difference in this x vivo test [29:25}

• No financial risk [30:00]

• Great value to research and future patients [31:57]

• MIT intent [34:57]

• Great creative minds in scientific research [36:15]

• Future of Travera’s efforts [36:55]

• The bigger plan [39:01]

• FDA approval/CLIA certification [40:05]

• Laboratory Developed Test (LDT) [40:21]

• Potential to greatly benefit newly diagnosed patients[41:49]

• Microchip specs [43:45]

• Physics vs biochemistry[46:20]

• Simple comparison to a diving board [47:05]

• Speed and logic [49:47]

• If someone is listening today and is interested [51:30]

• [e-mail] [52:23]

• PHI and HIPAA [53:35]

• Hearing from those who know best [55:03]

• Thanks for listening! [56:19]

Stay Connected

Podcast, Spotify, Anchor, research, advocacy, cancer, Travera, genomics, DNA, MIT, FDA, CLIA, LDT, cancer research, technology, cancer technology, innovation, groundbreaking, late-stage cancer, stage 4 cancer, uterine cancer, ovarian cancer, leukemia